A study of 47 COVID-19 patients in China found that higher complement C3 levels and longer time to negative viral RNA conversion were independently associated with delayed hospital discharge. Patients with delayed discharge were also more likely to have received thymalfasin (thymosin alpha-1) treatment, though this association likely reflects greater disease severity rather than a harmful effect of the drug. Dynamic monitoring of C3 and viral RNA levels may help predict which patients will need longer hospitalization.
Lin, Peihuang; Chen, Wenhuang; Huang, Hongbo; Lin, Yijian; Cai, Maosheng; Lin, Dongheng; Cai, Hehui; Su, Zhijun; Zhuang, Xibin; Yu, Xueping